TrialSpark logo

Moderate-to-Severe COPD?

Learn more about a clinical trial near you to assess the safety and effectiveness of a new study treatment for moderate to severe COPD. Call now to see if you may qualify: +1 (646-440-0560).

  • noun help 2725787

    Help others with COPD.

  • noun medical test results 3302706

    Visit with board-certified physicians.

  • Money

    Receive compensation for your time.

What is the purpose of the study?

Chronic obstructive pulmonary disease (COPD) is a chronic condition that can be difficult to manage. We're working on providing new options to potentially help you achieve better control of your symptoms. The AERIFY studies are testing a new treatment for patients with moderate-to-severe COPD that experience frequent exacerbations.

If you’re interested in seeing if you may qualify, you can speak with one of our Nurse Enrollment Specialists now at +1 646-440-0560.

Potential Reasons to Participate:

  • Advance COPD research.

  • Visit with board-certified physicians.

  • Help others with COPD.

  • Receive compensation for your time.

Download a PDF of the study details.

Study Overview

Research sites across the U.S. are currently enrolling participants in a trial to investigate a new treatment for adults (ages 40-85) with moderate-to-severe COPD and a history of smoking.

Volunteers are critical in helping medical researchers develop new options for patients with COPD. If you're interested in participating, you may either call one of our TrialSpark Nurse Enrollment Specialists directly at +1 646-440-0560 or complete the short online questionnaire.

TrialSpark helps to connect individuals that are looking for new treatment options with clinical research sites. If you qualify, you will have the option to schedule a brief call with a study team member to discuss your eligibility. We are here to help patients learn about what's involved in clinical trials and study participation.

How to See If You Qualify

  1. You can either complete a short (<5 min) questionnaire or speak directly with one of our Nurse Enrollment Specialists at +1 646-440-0560 to see if you may be eligible for this study. The information you provide is securely stored and encrypted under HIPAA.

  2. Speak to a Nurse Enrollment Specialist

    If you choose to first complete the short questionnaire, you’ll then schedule a ~20 min call with a nurse at a time that's convenient for you. The nurse will address your questions and confirm your possible eligibility.

  3. Schedule with the Study Doctor

    Based on the call and medical history, if you're eligible and interested in participating, you'll be connected with the research site near you for an in-person screening visit.

Why Participate?

  • Advance COPD research.

    Clinical trials help you to better understand your condition and help inform the development of future treatments.

  • Visit with board-certified physicians.

    All study-related mediciations, analysis, procedures, and clinic visits with study doctors will be provided at no cost to you or your insurance company.

  • Receive support for COPD medication costs.

    If you qualify and enroll, you will receive a voucher for complimentary approved COPD medications while participating in this study.

  • Receive compensation for your time.

    Compensation and travel reimbursement may be available. You can discuss support / stipends with study staff.

Taking part in clinical trials for COPD gives patients an opportunity to contribute to knowledge of and progress against the disease while also getting up-to-date care from experts.

American Lung Association

Taking part in clinical trials for COPD gives patients an opportunity to contribute to knowledge of and progress against the disease while also getting up-to-date care from experts.

American Lung Association

What to Expect If You Enroll

  1. Screening Period (3-5 weeks) As a potential research volunteer, you will have the opportunity to review the consent document fully to make an educated decision about whether to participate in the trial. If you consent, the study doctor will perform assessments to confirm that you are eligible to participate. Enrolled participants will be randomly assigned either the investigational treatment or the placebo.

  2. Treatment Period (52 weeks) The study medication is an injection taken every other week that potentially reduces inflammation in the lungs. To monitor safety and study progress, certain study visits will include: history and physical exam, spirometry testing, injection of study medication (Itepekimab), electrocardiogram (EKG), blood tests, and questionnaires.

  3. Follow-up (20 weeks) After treatment ends, the study doctor will continue to follow up with you. There are 3 visits during the follow-up period, including the end of study (last) visit, to thoroughly monitor and evaluate patient safety

Explore potential new options for COPD.

Express your interest in a clinical trial today.